Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

Name: Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
License: Public Domain

National Institutes of Health Clinical Center (CC)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

kidney cancer, melanoma (skin), unspecified adult solid tumor, protocol specific

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623546
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.